J Korean Neurosurg Soc.  2022 Nov;65(6):853-860. 10.3340/jkns.2021.0288.

Antiemetic Prophylaxis with Ramosetron for Postoperative Nausea and Vomiting in Patients Undergoing Microvascular Decompression : A Prospective, Randomized Controlled Trial

Affiliations
  • 1Department of Anesthesiology & Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
  • 2Department of Anesthesiology & Pain Medicine, Seoul National University College of Medicine, Seoul, Korea
  • 3Department of Neurosurgery, Seoul National University Bundang Hospital, Seongnam, Korea
  • 4Department of Neurosurgery, Seoul National University College of Medicine, Seoul, Korea

Abstract


Objective
: This prospective, randomized, double-blinded trial aimed to evaluate the efficacy and safety of prophylactic ramosetron administration against postoperative nausea and vomiting (PONV) in patients undergoing microvascular decompression (MVD).
Methods
: In this study, 100 patients undergoing MVD were randomly allocated to the control (normal saline, 2 mL) or ramosetron (ramosetron, 0.3 mg) groups at the end of surgery. The incidence and severity of PONV, need for rescue antiemetics, patient satisfaction score, duration of hospital stay, and the occurrence of adverse events were evaluated 48 hours post-surgery.
Results
: Data obtained from 97 patients were included in the final analysis. The incidence of PONV was significantly lower in the ramosetron group than in the control group throughout the 48-hour postoperative period (29.2% vs. 51.0%, p=0.028). A similar trend was observed with regard to PONV severity (p=0.041). The need for rescue antiemetics, satisfaction score, duration of hospital stays, and the occurrence of adverse events did not significantly differ between the groups.
Conclusion
: Prophylactic ramosetron administration reduced the incidence and severity of PONV in patients undergoing MVD without causing serious adverse events. Thus, ramosetron use may improve patient recovery following MVD.

Keyword

Antiemetics; Microvascular decompression surgery; Patient-controlled analgesia; Postoperative nausea and vomiting; Ramosetron

Figure

  • Fig. 1. Consort diagram of included and excluded patients. PCA : patient-controlled analgesia.


Reference

References

1. Apfel CC, Läärä E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology. 91:693–700. 1999.
2. Chandrakantan A, Glass PS. Multimodal therapies for postoperative nausea and vomiting, and pain. Br J Anaesth. 107:i27–i40. 2011.
3. Cho YJ, Choi GJ, Ahn EJ, Kang H. Pharmacologic interventions for postoperative nausea and vomiting after thyroidectomy: a systematic review and network meta-analysis. PLoS One. 16:e0243865. 2021.
4. Choi YS, Shim JK, Yoon DH, Jeon DH, Lee JY, Kwak YL. Effect of ramosetron on patient-controlled analgesia related nausea and vomiting after spine surgery in highly susceptible patients: comparison with ondansetron. Spine (Phila Pa 1976). 33:E602–E606. 2008.
5. Fabling JM, Gan TJ, El-Moalem HE, Warner DS, Borel CO. A randomized, double-blinded comparison of ondansetron, droperidol, and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy. Anesth Analg. 91:358–361. 2000.
6. Fabling JM, Gan TJ, El-Moalem HE, Warner DS, Borel CO. A randomized, double-blind comparison of ondansetron versus placebo for prevention of nausea and vomiting after infratentorial craniotomy. J Neurosurg Anesthesiol. 14:102–107. 2002.
7. Fabling JM, Gan TJ, Guy J, Borel CO, El-Moalem HE, Warner DS. Postoperative nausea and vomiting. a retrospective analysis in patients undergoing elective craniotomy. J Neurosurg Anesthesiol. 9:308–312. 1997.
8. Gan TJ, Belani KG, Bergese S, Chung F, Diemunsch P, Habib AS, et al. Fourth consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 131:411–448. 2020.
9. Go KO, Hwang K, Han JH. Surgical nuances to reduce and manage cerebrospinal fluid leaks after microvascular decompression. J Clin Med. 9:902. 2020.
10. Kang HY, Park SW, Lee S, Jeon JM, Oh ID, Choi JH. Effect of prophylactic palonosetron and sugammadex on postoperative nausea and vomiting in patients undergoing microvascular decompression under propofolmaintained anesthesia: a retrospective observational study. Medicine (Baltimore). 97:e13237. 2018.
11. Kim WO, Koo BN, Kim YK, Kil HK. Ramosetron for the prevention of postoperative nausea and vomiting (PONV): a meta-analysis. Korean J Anesthesiol. 61:405–412. 2011.
12. Kovac AL. Prevention and treatment of postoperative nausea and vomiting. Drugs. 59:213–243. 2000.
13. Lee HH, Kim HM, Lee JE, Jeon YT, Park S, Hwang K, et al. The effect of a transdermal scopolamine patch on postoperative nausea and vomiting after retromastoid craniectomy with microvascular decompression: a preliminary single center, double-blind, randomized controlled trial. J Clin Med. 9:156. 2020.
14. Lee SY, Lee JY, Park SY, Kim JH, Cho OG, Kim JS, et al. Prophylactic antiemetic efficacy of granisetron or ramosetron in patients undergoing thyroidectomy. Asian J Surg. 25:309–314. 2002.
15. Madenoglu H, Yildiz K, Dogru K, Kurtsoy A, Güler G, Boyaci A. Randomized, double-blinded comparison of tropisetron and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy. J Neurosurg Anesthesiol. 15:82–86. 2003.
16. McLaughlin MR, Jannetta PJ, Clyde BL, Subach BR, Comey CH, Resnick DK. Microvascular decompression of cranial nerves: lessons learned after 4400 operations. J Neurosurg. 90:1–8. 1999.
17. Meng L, Quinlan JJ. Assessing risk factors for postoperative nausea and vomiting: a retrospective study in patients undergoing retromastoid craniectomy with microvascular decompression of cranial nerves. J Neurosurg Anesthesiol. 18:235–239. 2006.
18. Neufeld SM, Newburn-Cook CV. The efficacy of 5-HT3 receptor antagonists for the prevention of postoperative nausea and vomiting after craniotomy: a meta-analysis. J Neurosurg Anesthesiol. 19:10–17. 2007.
19. Pierre S, Whelan R. Nausea and vomiting after surgery. CEACCP. 13:28–32. 2013.
20. Ryu JH, Lee JE, Lim YJ, Hong DM, Park HP, Han JI, et al. A prospective, randomized, double-blind, and multicenter trial of prophylactic effects of ramosetronon postoperative nausea and vomiting (PONV) after craniotomy: comparison with ondansetron. BMC Anesthesiol. 14:63. 2014.
21. Sato K, Sai S, Adachi T. Is microvascular decompression surgery a high risk for postoperative nausea and vomiting in patients undergoing craniotomy? J Anesth. 27:725–730. 2013.
22. Shaikh SI, Nagarekha D, Hegade G, Marutheesh M. Postoperative nausea and vomiting: a simple yet complex problem. Anesth Essays Res. 10:388–396. 2016.
23. Thongrong C, Chullabodhi P, Kasemsiri P, Kitkhuandee A, Plailaharn N, Sabangban L, et al. Effects of intraoperative dexamethasone and ondansetron on postoperative nausea and vomiting in microvascular decompression surgery: a randomized controlled study. Anesthesiol Res Pract. 2018:6297362. 2018.
24. Trevisani L, Cifalà V, Gilli G, Matarese V, Zelante A, Sartori S. Postanaesthetic discharge scoring system to assess patient recovery and discharge after colonoscopy. World J Gastrointest Endosc. 5:502–507. 2013.
25. Xu G, Zhao J, Liu Z, Liu G, Liu L, Ren C, et al. Dexmedetomidine combined with butorphanol or sufentanil for the prevention of postoperative nausea and vomiting in patients undergoing microvascular decompression: a randomized controlled trial. Front Med (Lausanne). 7:583031. 2020.
26. Yi MS, Kang H, Kim MK, Choi GJ, Park YH, Baek CW, et al. Relationship between the incidence and risk factors of postoperative nausea and vomiting in patients with intravenous patient-controlled analgesia. Asian J Surg. 41:301–306. 2018.
Full Text Links
  • JKNS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr